TerrAscend (TSNDF) Operating Expenses (2021 - 2026)
TerrAscend's (TSNDF) quarterly Operating Expenses came in at $23.1 million in Q1 2026, up 2.87% year-on-year from $22.4 million in Q1 2025, and down 13.93% on a QoQ basis from $26.8 million in Q4 2025.
TerrAscend (TSNDF) Operating Expenses (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Operating Expenses data on file, last reported at $23.1 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 2.87% year-over-year to $23.1 million in Q1 2026; TTM through Mar 2026 was $94.9 million, a 0.39% change from a year earlier, with the FY2025 full-year figure at $94.3 million, down 2.73% from the prior year.
- Operating Expenses for Q1 2026 stood at $23.1 million, down from $26.8 million in the prior quarter.
- Over the last five years, Operating Expenses for TSNDF reached as high as $361.2 million in Q3 2022 and fell as low as $15.4 million in Q4 2023.
- Historically, Operating Expenses has averaged $45.2 million across 5 years, with a median of $23.6 million in 2022.
- Across the five-year window, Operating Expenses soared 1452.61% in 2022 and plunged 91.67% in 2023, its largest moves.
- Year by year, Operating Expenses stood at $17.1 million in 2022, then slipped by 9.92% to $15.4 million in 2023, then soared by 52.57% to $23.5 million in 2024, then climbed by 14.32% to $26.8 million in 2025, then decreased by 13.93% to $23.1 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $23.1 million in Q1 2026, $26.8 million in Q4 2025, and $22.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 23.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.08 Mn |
| Dec 31, 2025 | 26.82 Mn |
| Sep 30, 2025 | 22.78 Mn |
| Jun 30, 2025 | 22.26 Mn |
| Mar 31, 2025 | 22.44 Mn |
| Dec 31, 2024 | 23.46 Mn |
| Sep 30, 2024 | 25.96 Mn |
| Jun 30, 2024 | 22.72 Mn |
| Mar 31, 2024 | 32.66 Mn |
| Dec 31, 2023 | 15.38 Mn |
| Sep 30, 2023 | 30.08 Mn |
| Jun 30, 2023 | 32.73 Mn |
| Mar 31, 2023 | 30.09 Mn |
| Dec 31, 2022 | 17.07 Mn |
| Sep 30, 2022 | 361.25 Mn |
| Jun 30, 2022 | 35.51 Mn |
| Mar 31, 2022 | 23.60 Mn |
| Dec 31, 2021 | 12.83 Mn |
| Sep 30, 2021 | 23.27 Mn |
| Jun 30, 2021 | 22.59 Mn |